Clin2
NCT07539805Possibly a fitRecruiting

Sertraline Plus Probiotic for Teen Depression

Major Depressive Disorder (MDD)Probiotic Intervention

Part of Mental health clinical trials.

This study tests whether combining sertraline (an antidepressant) with a specific probiotic called Lactobacillus crispatus can safely and effectively treat depression in teenagers. The probiotic may help by improving gut health, which researchers believe could support mental health.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
60 people
Ages
12 years to 18 years
Study type
Interventional

Who can take part

  • Be between 12 and 18 years old
  • Have been diagnosed with major depressive disorder and currently be in a depressed episode
  • Score at least 40 on the Child Depression Rating Scale (a measure of depression severity)
  • Not have other serious mental health conditions (except anxiety, which is okay)
  • Not have tried and failed two or more different antidepressants, or previously not tolerated sertraline
  • Not be at high risk for suicide, and not have recently used antibiotics, antifungals, or probiotics

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07645157Recruiting· Phase 2
Sertraline and Probiotics for Teen Depression

This study tests whether combining an antidepressant medication (sertraline) with special bacteria supplements (probiotics) can help treat depression in teenagers ages 12–18. Researchers believe the probiotics may help the medication work better by improving gut health.

Chongqing, Yuzhong
NCT07011693Not yet recruiting· Phase 4
Better treatment for teens with SSRI-resistant depression

This study tests whether switching to a different antidepressant or adding a second medication works better for teens (12-17) whose depression hasn't improved with a first SSRI. It compares two common strategies to find the best next step.

Chongqing, Chongqing Municipality
NCT07728253Not yet recruiting
Probiotic for moderate to severe depression

This trial tests a probiotic called IBNI617 for people with moderate to severe depression who are not currently taking antidepressant medication. It aims to see if this probiotic can help improve mood and depression symptoms.

Shanghai
NCT06827431Not yet recruiting· Phase 3
Testing ammoxetine for depression

This trial tests an investigational medication called ammoxetine for people with moderate to severe depression. It aims to see if the drug can reduce depressive symptoms and is for those who haven't had success with certain other antidepressants.

NCT05814640Recruiting· Phase 1/Phase 2
STAR-AD: Testing stepwise treatment for teen depression

This trial tests a step-by-step approach to treating moderate-to-severe depression in teens. It may help find a treatment path that improves mood while keeping care safe, including for some teens who have suicidal thoughts but do not need inpatient care.

Chongqing, Province
NCT06898788Recruiting· Early Phase 1
Probiotics for depression in teens and young adults

This study tests whether a probiotic supplement can help improve depression in young people who are already taking an SSRI antidepressant. If you join, you will take a probiotic or placebo for several weeks and have your mood and brain activity checked.

San Francisco, California

Hear when a new Probiotic Intervention trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.